The European Pharmacopoeia Commission

The European Pharmacopoeia Commission

On 17 December 2012, the Permanent Representation of Ukraine to the Council of Europe submitted to T. Jagland, Secretary General of the Council of Europe, a document on accession to the European Convention on the Elaboration of the European Pharmacopoeia, as amended by the Protocol of 16 November 1989. This text entered into force for Ukraine on 18 March 2013. Ukraine has become the 38th member of the European Pharmacopoeia.

The Convention on the Elaboration of European Pharmacopoeia, as amended in accordance with the provisions of the Protocol thereto, was developed by the Council of Europe with the aim of establishing uniform pharmacopoeial standards for the quality of medicines and harmonizing the specifications of medicinal substances. The Convention aims to gradually develop the Pharmacopoeia in Europe, is common to all member states, and defines a single set of characteristics and testing methods—official standards applicable in these countries for active substances and excipients used in the medicines manufacturing.

The Ukrainian delegation was formed by Decree of the President of Ukraine
No. 155/2024 dated 13 March 2024, “On the Ukrainian delegation to participate in meetings of the European Pharmacopoeia Commission.” The main tasks of the Ukrainian delegation’s participation in the meetings of the European Pharmacopoeia Commission are to ensure Ukraine’s interests in the development of pharmacopoeial standards for the quality of medicinal products. The results of joint efforts form the basis for further harmonization of the State Pharmacopoeia of Ukraine with the European Pharmacopoeia. The Commission meets three times a year, usually in March, June, and November in Strasbourg, France.